Accordingly, we hypothesized that different CAF content in Ccne1+ and Vgll3+ tumors is responsible for their distinct immune TME, and especially for blocking T cells at the tumor border in the Ccne1+ tumors. The gene discussed is VGLL3; the disease is neoplasm.